Ionis Releases News about Clinical Trial of ION582

Ionis Pharmaceuticals has released information regarding their clinical trial of ION582. The trial will move into Phase 3 and will be called Reveal.  

Ionis will be presenting more information at the FAST Global Science Summit on Saturday, November 9th at 10:10am EST.  

Read the community letter.

Read the press release.

Register virtually to watch Ionis’ presentation: https://cvent.me/rnAqQV